Less increase of copeptin and MR-proADM due to intervention with selenium and coenzyme Q10 combined: Results from a 4-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Less increase of copeptin and MR-proADM due to intervention with selenium and coenzyme Q10 combined: Results from a 4-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens
Authors
Keywords
-
Journal
BIOFACTORS
Volume 41, Issue 6, Pages 443-452
Publisher
Wiley
Online
2017-02-24
DOI
10.1002/biof.1245
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Low zinc and selenium concentrations in sepsis are associated with oxidative damage and inflammation
- (2015) K. Mertens et al. BRITISH JOURNAL OF ANAESTHESIA
- Vasopressin attenuates ischemia–reperfusion injury via reduction of oxidative stress and inhibition of mitochondrial permeability transition pore opening in rat hearts
- (2015) Afshin Nazari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Copeptin (C-terminal pro Arginine-Vasopressin) is an Independent Long-Term Prognostic Marker in Heart Failure with Reduced Ejection Fraction
- (2015) Zoltán Pozsonyi et al. Heart Lung and Circulation
- Reduced Coenzyme Q10 Decreases Urinary 8-Oxo-7,8-Dihydro-2′-Deoxyguanosine Concentrations in Healthy Young Female Subjects
- (2015) Kimiko Ito et al. JOURNAL OF MEDICINAL FOOD
- Selenium and coenzyme Q10 interrelationship in cardiovascular diseases – A clinician's point of view
- (2015) Urban Alehagen et al. JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
- Lipophilic antioxidants prevent lipopolysaccharide-induced mitochondrial dysfunction through mitochondrial biogenesis improvement
- (2015) Pedro Bullón et al. PHARMACOLOGICAL RESEARCH
- Markers of innate immune activity in patients with type 1 and type 2 diabetes mellitus and the effect of the anti-oxidant coenzyme Q10 on inflammatory activity
- (2014) H. Brauner et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- The Effect of Coenzyme Q 10 on Morbidity and Mortality in Chronic Heart Failure
- (2014) Svend A. Mortensen et al. JACC-Heart Failure
- Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial
- (2013) Bor-Jen Lee et al. Nutrition Journal
- Effect of selenium and Q10 on the cardiac biomarker NT-proBNP
- (2013) Peter Johansson et al. SCANDINAVIAN CARDIOVASCULAR JOURNAL
- Oxidative stress as a predictor of cardiovascular events in coronary artery disease patients
- (2012) Cristina Vassalle et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
- (2012) et al. EUROPEAN JOURNAL OF HEART FAILURE
- Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: A 5-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens
- (2012) Urban Alehagen et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Pro–A-Type Natriuretic Peptide, Proadrenomedullin, and N-Terminal Pro–B-Type Natriuretic Peptide Used in a Multimarker Strategy in Primary Health Care in Risk Assessment of Patients With Symptoms of Heart Failure
- (2012) Urban Alehagen et al. JOURNAL OF CARDIAC FAILURE
- The Role of Selenium in Inflammation and Immunity: From Molecular Mechanisms to Therapeutic Opportunities
- (2011) Zhi Huang et al. ANTIOXIDANTS & REDOX SIGNALING
- Increased 90-Day Mortality in Patients With Acute Heart Failure With Elevated Copeptin
- (2011) Alan Maisel et al. Circulation-Heart Failure
- Association of Copeptin and N-Terminal proBNP Concentrations With Risk of Cardiovascular Death in Older Patients With Symptoms of Heart Failure
- (2011) Urban Alehagen JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease
- (2011) Bor-Jen Lee et al. NUTRITION
- Selenium in Human Health and Disease
- (2010) Susan J. Fairweather-Tait et al. ANTIOXIDANTS & REDOX SIGNALING
- Copeptin, IGFBP-1, and Cardiovascular Prognosis in Patients With Type 2 Diabetes and Acute Myocardial Infarction: A report from the DIGAMI 2 trial
- (2010) L. G. Mellbin et al. DIABETES CARE
- Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure
- (2010) Stephan von Haehling et al. EUROPEAN JOURNAL OF HEART FAILURE
- Copeptin Improves Early Diagnosis of Acute Myocardial Infarction
- (2010) Till Keller et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Mid-Region Pro-Hormone Markers for Diagnosis and Prognosis in Acute Dyspnea
- (2010) Alan Maisel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Selenium and the Selenoprotein Thioredoxin Reductase in the Prevention, Treatment and Diagnostics of Cancer
- (2009) Markus Selenius et al. ANTIOXIDANTS & REDOX SIGNALING
- The human selenoproteome: recent insights into functions and regulation
- (2009) M. A. Reeves et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Distribution and Correlates of Midregional Proadrenomedullin in the General Population
- (2009) J. G. Smith et al. CLINICAL CHEMISTRY
- C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study
- (2009) A. A. Voors et al. EUROPEAN HEART JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More